Esraa successfully defended her thesis in 2025, which was titled: The influence of CYP2C19 genetic variants on the therapeutic efficacy and safety of Clopidogrel in stroke patients.
Search for Esraa Ayad Al-Meshaiki's papers on the Research page
Esraa successfully defended her thesis in 2025, which was titled: The influence of CYP2C19 genetic variants on the therapeutic efficacy and safety of Clopidogrel in stroke patients.
Search for Esraa Ayad Al-Meshaiki's papers on the Research page